Tumor‐infiltrating CD8+ T cells are thought to represent the effector phenotype, which is considered the main anti‐tumor actor in CRC, hepatocellular carcinoma and many other cancers.37, 38, 39. This evidence concerns the gene CD8A and hepatocellular carcinoma.